{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:19:49Z","timestamp":1777616389773,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T00:00:00Z","timestamp":1518393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T00:00:00Z","timestamp":1518393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/s41408-018-0052-0","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T14:47:41Z","timestamp":1518446861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Rac1 is a novel therapeutic target in mantle cell lymphoma"],"prefix":"10.1038","volume":"8","author":[{"given":"Tian","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengfeng","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley L.","family":"Hein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songfei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy C.","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Enke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Vose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,12]]},"reference":[{"key":"52_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-015-0460-2","volume":"17","author":"A Kumar","year":"2015","unstructured":"Kumar, A. Novel agents in mantle cell lymphoma. Curr. Oncol. Rep. 17, 34 (2015).","journal-title":"Curr. Oncol. Rep."},{"key":"52_CR2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1200\/JCO.2008.16.8435","volume":"27","author":"A Herrmann","year":"2009","unstructured":"Herrmann, A. et al. Improvement of overall survival in advanced stage mantle cell lymphoma. J. Clin. Oncol. 27, 511\u2013518 (2009).","journal-title":"J. Clin. Oncol."},{"key":"52_CR3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s00018-008-8552-x","volume":"66","author":"EE Bosco","year":"2009","unstructured":"Bosco, E. E., Mulloy, J. C. & Zheng, Y. Rac1 GTPase: a \u201cRac\u201d of all trades. Cell Mol. Life Sci. 66, 370\u2013374 (2009).","journal-title":"Cell Mol. Life Sci."},{"key":"52_CR4","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1053\/j.gastro.2011.04.043","volume":"141","author":"I Heid","year":"2011","unstructured":"Heid, I. et al Early requirement of Rac1 in a mouse model of pancreatic cancer. Gastroenterology 141, 719\u2013730 (2011).","journal-title":"Gastroenterology"},{"key":"52_CR5","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.1038\/onc.2016.163","volume":"35","author":"AL Hein","year":"2016","unstructured":"Hein, A. L. et al. RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment. Oncogene 35, 6319\u20136329 (2016).","journal-title":"Oncogene"},{"key":"52_CR6","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.1182\/blood-2011-04-351817","volume":"118","author":"B Mizukawa","year":"2011","unstructured":"Mizukawa, B. et al. Inhibition of Rac GTPase signaling and downstream prosurvival Bcl-2 proteins as combination targeted therapy in MLL-AF9 leukemia. Blood 118, 5235\u20135245 (2011).","journal-title":"Blood"},{"key":"52_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/sj.onc.1205036","volume":"21","author":"C Murga","year":"2002","unstructured":"Murga, C., Zohar, M., Teramoto, H. & Gutkind, J. S. Rac1 and RhoG promote cell survival by the activation of PI3K and Akt, independently of their ability to stimulate JNK and NF-kappaB. Oncogene 21, 207\u2013216 (2002).","journal-title":"Oncogene"},{"key":"52_CR8","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3324\/haematol.2016.159160","volume":"102","author":"C Bi","year":"2017","unstructured":"Bi, C. et al. Inhibition of 4EBP phosphorylation mediates the cytotoxic effect of mechanistic target of rapamycin kinase inhibitors in aggressive B-cell lymphomas. Haematologica 102, 755\u2013764 (2017).","journal-title":"Haematologica"},{"key":"52_CR9","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/leu.2011.305","volume":"26","author":"E Rao","year":"2012","unstructured":"Rao, E. et al. The miRNA-17 approximately 92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K\/AKT pathway activation. Leukemia 26, 1064\u20131072 (2012).","journal-title":"Leukemia"},{"key":"52_CR10","doi-asserted-by":"publisher","first-page":"5622","DOI":"10.1182\/blood-2010-05-285866","volume":"116","author":"JB Dennison","year":"2010","unstructured":"Dennison, J. B. et al. 8-Aminoadenosine inhibits Akt\/mTOR and Erk signaling in mantle cell lymphoma. Blood 116, 5622\u20135630 (2010).","journal-title":"Blood"},{"key":"52_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","volume":"3","author":"A Rosenwald","year":"2003","unstructured":"Rosenwald, A. et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 3, 185\u2013197 (2003).","journal-title":"Cancer Cell"},{"key":"52_CR12","doi-asserted-by":"publisher","first-page":"7618","DOI":"10.1073\/pnas.0307512101","volume":"101","author":"Y Gao","year":"2004","unstructured":"Gao, Y., Dickerson, J. B., Guo, F., Zheng, J. & Zheng, Y. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc. Natl Acad. Sci. USA 101, 7618\u20137623 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"52_CR13","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nrc2230","volume":"7","author":"P Jares","year":"2007","unstructured":"Jares, P., Colomer, D. & Campo, E. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat. Rev. Cancer 7, 750\u2013762 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"52_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1126\/science.1089709","volume":"302","author":"MJ Walmsley","year":"2003","unstructured":"Walmsley, M. J. et al. Critical roles for Rac1 and Rac2 GTPases in B cell development and signaling. Science 302, 459\u2013462 (2003).","journal-title":"Science"},{"key":"52_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","volume":"117","author":"P Perez-Galan","year":"2011","unstructured":"Perez-Galan, P., Dreyling, M. & Wiestner, A. Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era. Blood 117, 26\u201338 (2011).","journal-title":"Blood"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-018-0052-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-018-0052-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-018-0052-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T11:33:33Z","timestamp":1671536013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-018-0052-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,12]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2]]}},"alternative-id":["52"],"URL":"https:\/\/doi.org\/10.1038\/s41408-018-0052-0","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,12]]},"assertion":[{"value":"7 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"17"}}